Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Apellis Pharmaceuticals Inc Share Price

APLS

NSQ

$22.05

-$0.26

(-1.17%)

Industry: Biotechnology Sector: Health Care

Apellis Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Apellis Pharmaceuticals Inc Share Price Chart

Apellis Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$2.82B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

63.7429

Volume

This is the total number of shares traded during the most recent trading day.

1.34M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.24

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$16.1 L

$30.48 H

$22.05

About Apellis Pharmaceuticals Inc, Common Stock

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops EMPAVELI to treat C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, hematopoietic stem cell transplantation-associated thrombotic microangiopathy, focal segmental glomerulosclerosis, and delayed graft function; and APL-3007, a small interfering RNA, or siRNA for the treatment of GA. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Apellis Pharmaceuticals Inc Stock Returns

Time Frame	APLS	Sector	S&P500
1-Week Return	-1.11%	0.91%	2.13%
1-Month Return	-3.84%	-0.72%	-0.47%
3-Month Return	11.44%	2.24%	1.29%
6-Month Return	-6.65%	19.1%	7.71%
1-Year Return	-21.75%	7.15%	14.7%
3-Year Return	-57.02%	16.96%	67.75%
5-Year Return	-52.18%	33.23%	76.25%
10-Year Return	59.02%	142.74%	271.83%

Time Frame	APLS	Sector	S&P500
1-Week Return	-44.12%	60.38%	200.11%
1-Month Return	-37.90%	-8.42%	-5.57%
3-Month Return	55.16%	9.40%	5.34%
6-Month Return	-13.02%	42.54%	16.25%
1-Year Return	-21.75%	7.15%	14.70%
3-Year Return	-24.53%	5.36%	18.82%
5-Year Return	-13.72%	5.91%	12.00%
10-Year Return	4.75%	9.27%	14.03%

Apellis Pharmaceuticals Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	250.65M	66.56M	75.42M	396.59M	781.37M	[{"date":"2020-12-31","value":32.08,"profit":true},{"date":"2021-12-31","value":8.52,"profit":true},{"date":"2022-12-31","value":9.65,"profit":true},{"date":"2023-12-31","value":50.76,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	25.05M	5.20M	5.64M	58.51M	117.72M	[{"date":"2020-12-31","value":21.28,"profit":true},{"date":"2021-12-31","value":4.42,"profit":true},{"date":"2022-12-31","value":4.79,"profit":true},{"date":"2023-12-31","value":49.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	225.60M	61.36M	69.79M	338.08M	663.64M	[{"date":"2020-12-31","value":33.99,"profit":true},{"date":"2021-12-31","value":9.25,"profit":true},{"date":"2022-12-31","value":10.52,"profit":true},{"date":"2023-12-31","value":50.94,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	90.01%	92.19%	92.53%	85.25%	84.93%	[{"date":"2020-12-31","value":97.27,"profit":true},{"date":"2021-12-31","value":99.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.13,"profit":true},{"date":"2024-12-31","value":91.79,"profit":true}]

Operating Expenses	439.32M	597.64M	664.40M	855.20M	828.62M	[{"date":"2020-12-31","value":51.37,"profit":true},{"date":"2021-12-31","value":69.88,"profit":true},{"date":"2022-12-31","value":77.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.89,"profit":true}]
Operating Income	(213.73M)	(536.28M)	(594.61M)	(517.12M)	(164.98M)	[{"date":"2020-12-31","value":-21372600000,"profit":false},{"date":"2021-12-31","value":-53627700000,"profit":false},{"date":"2022-12-31","value":-59461300000,"profit":false},{"date":"2023-12-31","value":-51712100000,"profit":false},{"date":"2024-12-31","value":-16497900000,"profit":false}]
Total Non-Operating Income/Expense	(155.08M)	(222.55M)	(80.60M)	(18.02M)	(59.35M)	[{"date":"2020-12-31","value":-15507600000,"profit":false},{"date":"2021-12-31","value":-22254800000,"profit":false},{"date":"2022-12-31","value":-8060200000,"profit":false},{"date":"2023-12-31","value":-1802300000,"profit":false},{"date":"2024-12-31","value":-5935500000,"profit":false}]
Pre-Tax Income	(343.03M)	(746.00M)	(651.50M)	(526.50M)	(196.72M)	[{"date":"2020-12-31","value":-34302900000,"profit":false},{"date":"2021-12-31","value":-74600200000,"profit":false},{"date":"2022-12-31","value":-65150300000,"profit":false},{"date":"2023-12-31","value":-52649600000,"profit":false},{"date":"2024-12-31","value":-19671600000,"profit":false}]
Income Taxes	1.84M	352.00K	669.00K	2.13M	1.16M	[{"date":"2020-12-31","value":86.54,"profit":true},{"date":"2021-12-31","value":16.51,"profit":true},{"date":"2022-12-31","value":31.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":54.5,"profit":true}]
Income After Taxes	(344.87M)	(746.35M)	(652.17M)	(528.63M)	(197.88M)	[{"date":"2020-12-31","value":-34487400000,"profit":false},{"date":"2021-12-31","value":-74635400000,"profit":false},{"date":"2022-12-31","value":-65217200000,"profit":false},{"date":"2023-12-31","value":-52862800000,"profit":false},{"date":"2024-12-31","value":-19787800000,"profit":false}]

Income From Continuous Operations	(344.87M)	(746.35M)	(652.17M)	(528.63M)	(197.88M)	[{"date":"2020-12-31","value":-34487400000,"profit":false},{"date":"2021-12-31","value":-74635400000,"profit":false},{"date":"2022-12-31","value":-65217200000,"profit":false},{"date":"2023-12-31","value":-52862800000,"profit":false},{"date":"2024-12-31","value":-19787800000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(344.87M)	(746.35M)	(652.17M)	(528.63M)	(197.88M)	[{"date":"2020-12-31","value":-34487400000,"profit":false},{"date":"2021-12-31","value":-74635400000,"profit":false},{"date":"2022-12-31","value":-65217200000,"profit":false},{"date":"2023-12-31","value":-52862800000,"profit":false},{"date":"2024-12-31","value":-19787800000,"profit":false}]

EPS (Diluted)	(4.72)	(8.93)	(6.13)	(4.48)	(1.45)	[{"date":"2020-12-31","value":-472,"profit":false},{"date":"2021-12-31","value":-893,"profit":false},{"date":"2022-12-31","value":-613,"profit":false},{"date":"2023-12-31","value":-448,"profit":false},{"date":"2024-12-31","value":-145.24,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	(73.44%)	13.31%	425.83%	97.02%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-17.25,"profit":false},{"date":"2022-12-31","value":3.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":22.78,"profit":true}]
Cost of Revenue	-	(79.24%)	8.38%	938.15%	101.20%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-8.45,"profit":false},{"date":"2022-12-31","value":0.89,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":10.79,"profit":true}]
Gross Profit	-	(72.80%)	13.73%	384.45%	96.30%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-18.94,"profit":false},{"date":"2022-12-31","value":3.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":25.05,"profit":true}]
Gross Margin	-	2.42%	0.37%	(7.87%)	(0.37%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":15.19,"profit":true},{"date":"2023-12-31","value":-324.57,"profit":false},{"date":"2024-12-31","value":-15.15,"profit":false}]

Operating Expenses	-	36.04%	11.17%	28.72%	(3.11%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":31,"profit":true},{"date":"2023-12-31","value":79.69,"profit":true},{"date":"2024-12-31","value":-8.62,"profit":false}]
Operating Income	-	150.92%	10.88%	(13.03%)	(68.10%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":7.21,"profit":true},{"date":"2023-12-31","value":-8.64,"profit":false},{"date":"2024-12-31","value":-45.12,"profit":false}]
Total Non-Operating Income/Expense	-	43.51%	(63.78%)	(77.64%)	229.33%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":18.97,"profit":true},{"date":"2022-12-31","value":-27.81,"profit":false},{"date":"2023-12-31","value":-33.86,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	-	117.47%	(12.67%)	(19.19%)	(62.64%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-10.78,"profit":false},{"date":"2023-12-31","value":-16.33,"profit":false},{"date":"2024-12-31","value":-53.32,"profit":false}]
Income Taxes	-	(80.92%)	90.06%	218.68%	(45.50%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-37,"profit":false},{"date":"2022-12-31","value":41.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-20.8,"profit":false}]
Income After Taxes	-	116.41%	(12.62%)	(18.94%)	(62.57%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-10.84,"profit":false},{"date":"2023-12-31","value":-16.27,"profit":false},{"date":"2024-12-31","value":-53.75,"profit":false}]

Income From Continuous Operations	-	116.41%	(12.62%)	(18.94%)	(62.57%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-10.84,"profit":false},{"date":"2023-12-31","value":-16.27,"profit":false},{"date":"2024-12-31","value":-53.75,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	116.41%	(12.62%)	(18.94%)	(62.57%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-10.84,"profit":false},{"date":"2023-12-31","value":-16.27,"profit":false},{"date":"2024-12-31","value":-53.75,"profit":false}]

EPS (Diluted)	-	89.19%	(31.35%)	(26.92%)	(67.58%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-35.15,"profit":false},{"date":"2023-12-31","value":-30.18,"profit":false},{"date":"2024-12-31","value":-75.77,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	196.83M	212.53M	166.80M	178.49M	458.58M	[{"date":"2024-09-30","value":42.92,"profit":true},{"date":"2024-12-31","value":46.35,"profit":true},{"date":"2025-03-31","value":36.37,"profit":true},{"date":"2025-06-30","value":38.92,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	33.56M	40.86M	34.36M	14.07M	24.53M	[{"date":"2024-09-30","value":82.13,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":84.1,"profit":true},{"date":"2025-06-30","value":34.44,"profit":true},{"date":"2025-09-30","value":60.04,"profit":true}]
Gross Profit	163.27M	171.67M	132.44M	164.42M	434.05M	[{"date":"2024-09-30","value":37.62,"profit":true},{"date":"2024-12-31","value":39.55,"profit":true},{"date":"2025-03-31","value":30.51,"profit":true},{"date":"2025-06-30","value":37.88,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	82.95%	80.78%	79.40%	92.12%	94.65%	[{"date":"2024-09-30","value":87.64,"profit":true},{"date":"2024-12-31","value":85.34,"profit":true},{"date":"2025-03-31","value":83.89,"profit":true},{"date":"2025-06-30","value":97.32,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	210.55M	197.84M	215.76M	197.71M	210.86M	[{"date":"2024-09-30","value":97.58,"profit":true},{"date":"2024-12-31","value":91.69,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":91.63,"profit":true},{"date":"2025-09-30","value":97.73,"profit":true}]
Operating Income	(47.28M)	(26.16M)	(83.33M)	(33.29M)	223.18M	[{"date":"2024-09-30","value":-21.18,"profit":false},{"date":"2024-12-31","value":-11.72,"profit":false},{"date":"2025-03-31","value":-37.34,"profit":false},{"date":"2025-06-30","value":-14.91,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Non-Operating Income/Expense	(19.22M)	(18.04M)	(16.95M)	(16.94M)	(13.77M)	[{"date":"2024-09-30","value":-1921600000,"profit":false},{"date":"2024-12-31","value":-1804100000,"profit":false},{"date":"2025-03-31","value":-1694700000,"profit":false},{"date":"2025-06-30","value":-1694400000,"profit":false},{"date":"2025-09-30","value":-1376900000,"profit":false}]
Pre-Tax Income	(56.85M)	(36.07M)	(91.88M)	(41.69M)	216.32M	[{"date":"2024-09-30","value":-26.28,"profit":false},{"date":"2024-12-31","value":-16.67,"profit":false},{"date":"2025-03-31","value":-42.48,"profit":false},{"date":"2025-06-30","value":-19.27,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income Taxes	592.00K	286.00K	341.00K	466.00K	602.00K	[{"date":"2024-09-30","value":98.34,"profit":true},{"date":"2024-12-31","value":47.51,"profit":true},{"date":"2025-03-31","value":56.64,"profit":true},{"date":"2025-06-30","value":77.41,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Income After Taxes	(57.45M)	(36.35M)	(92.22M)	(42.15M)	215.72M	[{"date":"2024-09-30","value":-26.63,"profit":false},{"date":"2024-12-31","value":-16.85,"profit":false},{"date":"2025-03-31","value":-42.75,"profit":false},{"date":"2025-06-30","value":-19.54,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Income From Continuous Operations	(57.45M)	(36.35M)	(92.22M)	(42.15M)	215.72M	[{"date":"2024-09-30","value":-26.63,"profit":false},{"date":"2024-12-31","value":-16.85,"profit":false},{"date":"2025-03-31","value":-42.75,"profit":false},{"date":"2025-06-30","value":-19.54,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(57.45M)	(36.35M)	(92.22M)	(42.15M)	215.72M	[{"date":"2024-09-30","value":-26.63,"profit":false},{"date":"2024-12-31","value":-16.85,"profit":false},{"date":"2025-03-31","value":-42.75,"profit":false},{"date":"2025-06-30","value":-19.54,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

EPS (Diluted)	(0.46)	(0.29)	(0.74)	(0.33)	1.67	[{"date":"2024-09-30","value":-27.69,"profit":false},{"date":"2024-12-31","value":-17.37,"profit":false},{"date":"2025-03-31","value":-44.31,"profit":false},{"date":"2025-06-30","value":-19.76,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	7.98%	(21.52%)	7.01%	156.92%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":5.08,"profit":true},{"date":"2025-03-31","value":-13.71,"profit":false},{"date":"2025-06-30","value":4.47,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	-	21.75%	(15.90%)	(59.05%)	74.32%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":29.26,"profit":true},{"date":"2025-03-31","value":-21.39,"profit":false},{"date":"2025-06-30","value":-79.44,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	-	5.14%	(22.85%)	24.15%	163.98%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":3.14,"profit":true},{"date":"2025-03-31","value":-13.94,"profit":false},{"date":"2025-06-30","value":14.73,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	-	(2.62%)	(1.70%)	16.02%	2.75%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-16.37,"profit":false},{"date":"2025-03-31","value":-10.64,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":17.18,"profit":true}]

Operating Expenses	-	(6.04%)	9.06%	(8.37%)	6.65%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-66.65,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-92.35,"profit":false},{"date":"2025-09-30","value":73.43,"profit":true}]
Operating Income	-	(44.66%)	218.48%	(60.05%)	(770.50%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-20.44,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-27.49,"profit":false},{"date":"2025-09-30","value":-352.66,"profit":false}]
Total Non-Operating Income/Expense	-	(6.11%)	(6.06%)	(0.02%)	(18.74%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Pre-Tax Income	-	(36.56%)	154.76%	(54.63%)	(618.93%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-23.62,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-35.3,"profit":false},{"date":"2025-09-30","value":-399.93,"profit":false}]
Income Taxes	-	(51.69%)	19.23%	36.66%	29.18%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-141.01,"profit":false},{"date":"2025-03-31","value":52.46,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":79.62,"profit":true}]
Income After Taxes	-	(36.72%)	153.69%	(54.30%)	(611.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-23.89,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-35.33,"profit":false},{"date":"2025-09-30","value":-398.05,"profit":false}]

Income From Continuous Operations	-	(36.72%)	153.69%	(54.30%)	(611.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-23.89,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-35.33,"profit":false},{"date":"2025-09-30","value":-398.05,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(36.72%)	153.69%	(54.30%)	(611.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-23.89,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-35.33,"profit":false},{"date":"2025-09-30","value":-398.05,"profit":false}]

EPS (Diluted)	-	(37.28%)	155.17%	(55.41%)	(606.06%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-24.03,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-35.71,"profit":false},{"date":"2025-09-30","value":-390.57,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	917.19M	824.05M	719.52M	766.33M	788.95M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.84,"profit":true},{"date":"2022-12-31","value":78.45,"profit":true},{"date":"2023-12-31","value":83.55,"profit":true},{"date":"2024-12-31","value":86.02,"profit":true}]
Non-current Assets	43.38M	57.72M	40.69M	22.40M	96.10M	[{"date":"2020-12-31","value":45.14,"profit":true},{"date":"2021-12-31","value":60.06,"profit":true},{"date":"2022-12-31","value":42.35,"profit":true},{"date":"2023-12-31","value":23.31,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	960.57M	881.76M	760.22M	788.73M	885.05M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":91.8,"profit":true},{"date":"2022-12-31","value":79.14,"profit":true},{"date":"2023-12-31","value":82.11,"profit":true},{"date":"2024-12-31","value":92.14,"profit":true}]

Total Liabilities
Current Liabilities	128.33M	131.85M	167.61M	247.59M	185.51M	[{"date":"2020-12-31","value":51.83,"profit":true},{"date":"2021-12-31","value":53.25,"profit":true},{"date":"2022-12-31","value":67.7,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":74.92,"profit":true}]
Non-current Liabilities	627.68M	551.26M	422.74M	346.62M	471.00M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":87.82,"profit":true},{"date":"2022-12-31","value":67.35,"profit":true},{"date":"2023-12-31","value":55.22,"profit":true},{"date":"2024-12-31","value":75.04,"profit":true}]
Total Liabilities	756.01M	683.10M	590.35M	594.21M	656.51M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":90.36,"profit":true},{"date":"2022-12-31","value":78.09,"profit":true},{"date":"2023-12-31","value":78.6,"profit":true},{"date":"2024-12-31","value":86.84,"profit":true}]

Total Shareholders' equity
Common Stock	8.00K	10.00K	11.00K	12.00K	12.00K	[{"date":"2020-12-31","value":66.67,"profit":true},{"date":"2021-12-31","value":83.33,"profit":true},{"date":"2022-12-31","value":91.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(926.35M)	(1.66B)	(2.31B)	(2.84B)	(3.04B)	[{"date":"2020-12-31","value":-92634700000,"profit":false},{"date":"2021-12-31","value":-165668800000,"profit":false},{"date":"2022-12-31","value":-230886000000,"profit":false},{"date":"2023-12-31","value":-283748800000,"profit":false},{"date":"2024-12-31","value":-303536600000,"profit":false}]
Other Stockholders' Equity	1.13B	1.86B	2.48B	3.04B	3.27B	[{"date":"2020-12-31","value":34.62,"profit":true},{"date":"2021-12-31","value":56.85,"profit":true},{"date":"2022-12-31","value":75.89,"profit":true},{"date":"2023-12-31","value":92.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	204.56M	198.66M	169.87M	194.52M	228.54M	[{"date":"2020-12-31","value":89.51,"profit":true},{"date":"2021-12-31","value":86.93,"profit":true},{"date":"2022-12-31","value":74.33,"profit":true},{"date":"2023-12-31","value":85.12,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	960.57M	881.76M	760.22M	788.73M	885.05M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":91.8,"profit":true},{"date":"2022-12-31","value":79.14,"profit":true},{"date":"2023-12-31","value":82.11,"profit":true},{"date":"2024-12-31","value":92.14,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	(10.16%)	(12.68%)	6.51%	2.95%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-156.11,"profit":false},{"date":"2022-12-31","value":-194.98,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":45.38,"profit":true}]
Non-current Assets	-	33.06%	(29.50%)	(44.96%)	329.02%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":10.05,"profit":true},{"date":"2022-12-31","value":-8.96,"profit":false},{"date":"2023-12-31","value":-13.66,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	(8.20%)	(13.78%)	3.75%	12.21%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-67.18,"profit":false},{"date":"2022-12-31","value":-112.88,"profit":false},{"date":"2023-12-31","value":30.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	2.74%	27.12%	47.72%	(25.08%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.75,"profit":true},{"date":"2022-12-31","value":56.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-52.55,"profit":false}]
Non-current Liabilities	-	(12.18%)	(23.31%)	(18.01%)	35.89%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-33.93,"profit":false},{"date":"2022-12-31","value":-64.97,"profit":false},{"date":"2023-12-31","value":-50.18,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	-	(9.64%)	(13.58%)	0.65%	10.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-91.98,"profit":false},{"date":"2022-12-31","value":-129.51,"profit":false},{"date":"2023-12-31","value":6.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	25.00%	10.00%	9.09%	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":40,"profit":true},{"date":"2023-12-31","value":36.36,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	78.84%	39.37%	22.90%	6.97%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":49.93,"profit":true},{"date":"2023-12-31","value":29.04,"profit":true},{"date":"2024-12-31","value":8.85,"profit":true}]
Other Stockholders' Equity	-	64.23%	33.50%	22.42%	7.63%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":52.15,"profit":true},{"date":"2023-12-31","value":34.91,"profit":true},{"date":"2024-12-31","value":11.88,"profit":true}]
Total Shareholders' equity	-	(2.88%)	(14.49%)	14.51%	17.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-16.48,"profit":false},{"date":"2022-12-31","value":-82.87,"profit":false},{"date":"2023-12-31","value":82.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(8.20%)	(13.78%)	3.75%	12.21%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-67.18,"profit":false},{"date":"2022-12-31","value":-112.88,"profit":false},{"date":"2023-12-31","value":30.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	833.90M	788.95M	727.72M	755.61M	990.68M	[{"date":"2024-09-30","value":84.17,"profit":true},{"date":"2024-12-31","value":79.64,"profit":true},{"date":"2025-03-31","value":73.46,"profit":true},{"date":"2025-06-30","value":76.27,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	67.97M	96.10M	79.57M	65.78M	68.05M	[{"date":"2024-09-30","value":70.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":82.8,"profit":true},{"date":"2025-06-30","value":68.45,"profit":true},{"date":"2025-09-30","value":70.81,"profit":true}]
Total Assets	901.87M	885.05M	807.28M	821.39M	1.06B	[{"date":"2024-09-30","value":85.18,"profit":true},{"date":"2024-12-31","value":83.6,"profit":true},{"date":"2025-03-31","value":76.25,"profit":true},{"date":"2025-06-30","value":77.58,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	191.26M	185.51M	178.38M	200.66M	279.53M	[{"date":"2024-09-30","value":68.42,"profit":true},{"date":"2024-12-31","value":66.37,"profit":true},{"date":"2025-03-31","value":63.81,"profit":true},{"date":"2025-06-30","value":71.79,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	473.49M	471.00M	464.69M	464.43M	378.03M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99.48,"profit":true},{"date":"2025-03-31","value":98.14,"profit":true},{"date":"2025-06-30","value":98.09,"profit":true},{"date":"2025-09-30","value":79.84,"profit":true}]
Total Liabilities	664.75M	656.51M	643.07M	665.09M	657.55M	[{"date":"2024-09-30","value":99.95,"profit":true},{"date":"2024-12-31","value":98.71,"profit":true},{"date":"2025-03-31","value":96.69,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":98.87,"profit":true}]

Total Shareholders' equity
Common Stock	12.00K	12.00K	12.00K	12.00K	12.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(3.00B)	(3.04B)	(3.13B)	(3.17B)	(2.95B)	[{"date":"2024-09-30","value":-299901300000,"profit":false},{"date":"2024-12-31","value":-303536600000,"profit":false},{"date":"2025-03-31","value":-312759100000,"profit":false},{"date":"2025-06-30","value":-316974200000,"profit":false},{"date":"2025-09-30","value":-295402700000,"profit":false}]
Other Stockholders' Equity	3.24B	3.27B	3.29B	3.33B	3.36B	[{"date":"2024-09-30","value":96.48,"profit":true},{"date":"2024-12-31","value":97.31,"profit":true},{"date":"2025-03-31","value":98.13,"profit":true},{"date":"2025-06-30","value":99.14,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	237.12M	228.54M	164.22M	156.31M	401.17M	[{"date":"2024-09-30","value":59.11,"profit":true},{"date":"2024-12-31","value":56.97,"profit":true},{"date":"2025-03-31","value":40.93,"profit":true},{"date":"2025-06-30","value":38.96,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	901.87M	885.05M	807.28M	821.39M	1.06B	[{"date":"2024-09-30","value":85.18,"profit":true},{"date":"2024-12-31","value":83.6,"profit":true},{"date":"2025-03-31","value":76.25,"profit":true},{"date":"2025-06-30","value":77.58,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(5.39%)	(7.76%)	3.83%	31.11%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-17.32,"profit":false},{"date":"2025-03-31","value":-24.95,"profit":false},{"date":"2025-06-30","value":12.32,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	-	41.38%	(17.20%)	(17.33%)	3.45%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-41.57,"profit":false},{"date":"2025-06-30","value":-41.87,"profit":false},{"date":"2025-09-30","value":8.33,"profit":true}]
Total Assets	-	(1.86%)	(8.79%)	1.75%	28.89%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.45,"profit":false},{"date":"2025-03-31","value":-30.41,"profit":false},{"date":"2025-06-30","value":6.05,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(3.01%)	(3.84%)	12.49%	39.30%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-7.65,"profit":false},{"date":"2025-03-31","value":-9.78,"profit":false},{"date":"2025-06-30","value":31.78,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	-	(0.52%)	(1.34%)	(0.06%)	(18.60%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Liabilities	-	(1.24%)	(2.05%)	3.42%	(1.13%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-36.18,"profit":false},{"date":"2025-03-31","value":-59.81,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-33.07,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	1.21%	3.04%	1.35%	(6.81%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":39.9,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":44.36,"profit":true},{"date":"2025-09-30","value":-223.98,"profit":false}]
Other Stockholders' Equity	-	0.86%	0.85%	1.02%	0.87%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":84.19,"profit":true},{"date":"2025-03-31","value":82.6,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":84.98,"profit":true}]
Total Shareholders' equity	-	(3.62%)	(28.15%)	(4.82%)	156.66%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-2.31,"profit":false},{"date":"2025-03-31","value":-17.97,"profit":false},{"date":"2025-06-30","value":-3.08,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(1.86%)	(8.79%)	1.75%	28.89%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.45,"profit":false},{"date":"2025-03-31","value":-30.41,"profit":false},{"date":"2025-06-30","value":6.05,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(160.49M)	(563.13M)	(513.75M)	(594.74M)	(87.87M)	[{"date":"2020-12-31","value":-16048800000,"profit":false},{"date":"2021-12-31","value":-56312600000,"profit":false},{"date":"2022-12-31","value":-51374500000,"profit":false},{"date":"2023-12-31","value":-59473500000,"profit":false},{"date":"2024-12-31","value":-8786600000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(316.99M)	247.62M	59.89M	(674.00K)	(403.00K)	[{"date":"2020-12-31","value":-128.02,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.19,"profit":true},{"date":"2023-12-31","value":-0.27,"profit":false},{"date":"2024-12-31","value":-0.16,"profit":false}]

Financing Activities
Net Financing Cash Flow	692.18M	392.24M	365.66M	394.50M	149.24M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.67,"profit":true},{"date":"2022-12-31","value":52.83,"profit":true},{"date":"2023-12-31","value":56.99,"profit":true},{"date":"2024-12-31","value":21.56,"profit":true}]

Net Change in Cash	215.06M	74.71M	(88.68M)	(200.78M)	60.31M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":34.74,"profit":true},{"date":"2022-12-31","value":-41.24,"profit":false},{"date":"2023-12-31","value":-93.36,"profit":false},{"date":"2024-12-31","value":28.04,"profit":true}]

Free Cash Flow
Free Cash Flow	(165.91M)	(564.23M)	(515.27M)	(595.51M)	(88.27M)	[{"date":"2020-12-31","value":-16591000000,"profit":false},{"date":"2021-12-31","value":-56422900000,"profit":false},{"date":"2022-12-31","value":-51526900000,"profit":false},{"date":"2023-12-31","value":-59550800000,"profit":false},{"date":"2024-12-31","value":-8826900000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	250.88%	(8.77%)	15.76%	(85.23%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.5,"profit":false},{"date":"2023-12-31","value":6.28,"profit":true},{"date":"2024-12-31","value":-33.97,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(178.12%)	(75.81%)	(101.13%)	(40.21%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(43.33%)	(6.78%)	7.89%	(62.17%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-549.41,"profit":false},{"date":"2022-12-31","value":-85.91,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-788.24,"profit":false}]

Net Change in Cash	-	(65.26%)	(218.70%)	126.40%	(130.04%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-51.63,"profit":false},{"date":"2022-12-31","value":-173.02,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-102.88,"profit":false}]

Free Cash Flow
Free Cash Flow	-	240.08%	(8.68%)	15.57%	(85.18%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.61,"profit":false},{"date":"2023-12-31","value":6.49,"profit":true},{"date":"2024-12-31","value":-35.48,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	34.10M	19.36M	(53.41M)	4.45M	108.47M	[{"date":"2024-09-30","value":31.43,"profit":true},{"date":"2024-12-31","value":17.85,"profit":true},{"date":"2025-03-31","value":-49.24,"profit":false},{"date":"2025-06-30","value":4.1,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(20.00K)	(8.00K)	(49.00K)	(148.00K)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-2000000,"profit":false},{"date":"2025-03-31","value":-800000,"profit":false},{"date":"2025-06-30","value":-4900000,"profit":false},{"date":"2025-09-30","value":-14800000,"profit":false}]

Financing Activities
Net Financing Cash Flow	2.54M	(4.00M)	274.00K	6.56M	793.00K	[{"date":"2024-09-30","value":38.76,"profit":true},{"date":"2024-12-31","value":-60.99,"profit":false},{"date":"2025-03-31","value":4.18,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":12.09,"profit":true}]

Net Change in Cash	36.81M	14.38M	(52.78M)	11.64M	109.14M	[{"date":"2024-09-30","value":33.73,"profit":true},{"date":"2024-12-31","value":13.17,"profit":true},{"date":"2025-03-31","value":-48.37,"profit":false},{"date":"2025-06-30","value":10.66,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	34.10M	19.34M	(53.42M)	4.40M	108.32M	[{"date":"2024-09-30","value":31.48,"profit":true},{"date":"2024-12-31","value":17.85,"profit":true},{"date":"2025-03-31","value":-49.31,"profit":false},{"date":"2025-06-30","value":4.06,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(43.22%)	(375.88%)	(108.32%)	2340.22%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.85,"profit":false},{"date":"2025-03-31","value":-16.06,"profit":false},{"date":"2025-06-30","value":-4.63,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	(60.00%)	512.50%	202.04%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-11.71,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":39.42,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(257.36%)	(106.85%)	2293.43%	(87.91%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-11.22,"profit":false},{"date":"2025-03-31","value":-4.66,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-3.83,"profit":false}]

Net Change in Cash	-	(60.95%)	(467.20%)	(122.05%)	837.67%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-7.28,"profit":false},{"date":"2025-03-31","value":-55.77,"profit":false},{"date":"2025-06-30","value":-14.57,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(43.28%)	(376.20%)	(108.23%)	2364.06%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.83,"profit":false},{"date":"2025-03-31","value":-15.91,"profit":false},{"date":"2025-06-30","value":-4.58,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Apellis Pharmaceuticals Inc Ratios

Apellis Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	APLS
Cash Ratio	1.71
Current Ratio	3.54
Quick Ratio	3.10

Apellis Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	APLS
ROA (LTM)	5.13%
ROE (LTM)	14.10%

Apellis Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	APLS
Debt Ratio Lower is generally better. Negative is bad.	0.62
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.38

Apellis Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	APLS
Trailing PE	63.74
Forward PE	46.30
P/S (TTM)	2.78
P/B	7.03
Price/FCF	26
EV/R	2.77
EV/Ebitda	30.18

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Apellis Pharmaceuticals Inc share price today?

Apellis Pharmaceuticals Inc (APLS) share price today is $22.05

Can Indians buy Apellis Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Apellis Pharmaceuticals Inc (APLS) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in APLS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Apellis Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Apellis Pharmaceuticals Inc (APLS) via the Vested app. You can start investing in Apellis Pharmaceuticals Inc (APLS) with a minimum investment of $1.

How to invest in Apellis Pharmaceuticals Inc shares from India?

You can invest in shares of Apellis Pharmaceuticals Inc (APLS) via Vested in three simple steps:

Click on Sign Up or Invest in APLS stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Apellis Pharmaceuticals Inc shares

What is Apellis Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Apellis Pharmaceuticals Inc (APLS) is $30.48. The 52-week low price of Apellis Pharmaceuticals Inc (APLS) is $16.1.

What is Apellis Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Apellis Pharmaceuticals Inc (APLS) is 63.7429

What is Apellis Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Apellis Pharmaceuticals Inc (APLS) is 7.03

What is Apellis Pharmaceuticals Inc dividend yield?

The dividend yield of Apellis Pharmaceuticals Inc (APLS) is 0.00%

What is the Market Cap of Apellis Pharmaceuticals Inc?

The market capitalization of Apellis Pharmaceuticals Inc (APLS) is $2.82B

What is Apellis Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Apellis Pharmaceuticals Inc is APLS

How Can Investors Use Apellis Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Apellis Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Apellis Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Apellis Pharmaceuticals Inc shares for Indian investors?

When investing in Apellis Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Apellis Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Apellis Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Apellis Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Apellis Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Apellis Pharmaceuticals Inc Share Price

Apellis Pharmaceuticals Inc Analyst Forecast

Apellis Pharmaceuticals Inc Share Price Chart

Apellis Pharmaceuticals Inc Key Stock Metrics

About Apellis Pharmaceuticals Inc, Common Stock

Apellis Pharmaceuticals Inc Stock Returns

Apellis Pharmaceuticals Inc Financials

Apellis Pharmaceuticals Inc Ratios

Apellis Pharmaceuticals Inc Liquidity Ratios

Apellis Pharmaceuticals Inc Asset Efficiency Ratios

Apellis Pharmaceuticals Inc Liability Ratios

Apellis Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Apellis Pharmaceuticals Inc Share Price

Apellis Pharmaceuticals Inc Analyst Forecast

Apellis Pharmaceuticals Inc Share Price Chart

Apellis Pharmaceuticals Inc Key Stock Metrics

About Apellis Pharmaceuticals Inc, Common Stock

Apellis Pharmaceuticals Inc Stock Returns

Apellis Pharmaceuticals Inc Financials

Apellis Pharmaceuticals Inc Ratios

Apellis Pharmaceuticals Inc Liquidity Ratios

Apellis Pharmaceuticals Inc Asset Efficiency Ratios

Apellis Pharmaceuticals Inc Liability Ratios

Apellis Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²